Malignant Peritoneal Neoplasm Completed Phase Trials for Bevacizumab (DB00112)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01223235Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With BevacizumabTreatment